Congenital disorder of glycosylation type 1w
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
Our report expands both the genotype and phenotype of STT3A-CDG; demonstrating, as in most types of CDG, that there are multiple disease-causing variants in STT3A.
|
30701557 |
2019 |
Congenital disorder of glycosylation type 1w
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in STT3A and STT3B cause two congenital disorders of glycosylation.
|
23842455 |
2013 |
Congenital disorder of glycosylation type 1w
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in STT3A and STT3B cause two congenital disorders of glycosylation.
|
23842455 |
2013 |
Congenital disorder of glycosylation type 1w
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in STT3A and STT3B cause two congenital disorders of glycosylation.
|
23842455 |
2013 |
Congenital disorder of glycosylation type 1w
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in STT3A and STT3B cause two congenital disorders of glycosylation.
|
23842455 |
2013 |
Congenital disorder of glycosylation type 1w
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
Congenital disorder of glycosylation type 1w
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Global developmental delay
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in STT3A and STT3B cause two congenital disorders of glycosylation.
|
23842455 |
2013 |
Intellectual Disability
|
0.400 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Mutations in STT3A and STT3B cause two congenital disorders of glycosylation.
|
23842455 |
2013 |
Global developmental delay
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Intellectual Disability
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
Developmental delay (disorder)
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Mutations in STT3A and STT3B cause two congenital disorders of glycosylation.
|
23842455 |
2013 |
Schizophrenia
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Meta-analysis of this population of Indo-European and Dravidian ancestry identified three strongly associated variants with schizophrenia: STT3A (rs548181, p=1.47×10(-5)), NRG1 (rs17603876, p=8.66×10(-5)) and GRM7 (rs3864075, p=4.06×10(-3)).
|
25579050 |
2015 |
Schizophrenia
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Schizophrenia
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies five new schizophrenia loci.
|
21926974 |
2011 |
Schizophrenia
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies five new schizophrenia loci.
|
21926974 |
2011 |
Bipolar Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Child Development Disorders, Pervasive
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Attention deficit hyperactivity disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Attention deficit hyperactivity disorder
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Major Depressive Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|